-
1
-
-
79951554058
-
Stemming the global tsunami of cardiovascular disease
-
Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet 2011;377:529-532
-
(2011)
Lancet
, vol.377
, pp. 529-532
-
-
Anand, S.S.1
Yusuf, S.2
-
2
-
-
78449267756
-
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12, 064 survivors of myocardial infarction: A double-blind randomised trial
-
Armitage J, Bowman L, Wallendszus K et al. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12, 064 survivors of myocardial infarction: a double-blind randomised trial. Lancet 2010;376:1658-1669
-
(2010)
Lancet
, vol.376
, pp. 1658-1669
-
-
Armitage, J.1
Bowman, L.2
Wallendszus, K.3
-
3
-
-
33749030970
-
Gap between guidelines and practice: Attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation)
-
Assmann G, Benecke H, Neiss A et al. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation). Eur J Cardiovasc Prev Rehabil 2006;13:776-783
-
(2006)
Eur J Cardiovasc Prev Rehabil
, vol.13
, pp. 776-783
-
-
Assmann, G.1
Benecke, H.2
Neiss, A.3
-
4
-
-
18344368202
-
Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates
-
Baessler A, Fischer M, Huf V et al. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates. Int J Cardiol 2005;101:293-298
-
(2005)
Int J Cardiol
, vol.101
, pp. 293-298
-
-
Baessler, A.1
Fischer, M.2
Huf, V.3
-
5
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins
-
Baigent C, Keech A, Kearney PM et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
-
6
-
-
46049090018
-
The primary and secondary prevention of coronary artery disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition)
-
Becker RC, Meade TW, Berger PB et al. The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:776S-814
-
(2008)
Chest
, vol.133
, pp. 776S-814
-
-
Becker, R.C.1
Meade, T.W.2
Berger, P.B.3
-
7
-
-
84856245226
-
Lifetime risks of cardiovascular disease
-
Berry JD, Dyer A, Cai X et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012;366:321-329
-
(2012)
N Engl J Med
, vol.366
, pp. 321-329
-
-
Berry, J.D.1
Dyer, A.2
Cai, X.3
-
8
-
-
65249120929
-
Impact of a multifaceted intervention on cholesterol management in primary care practices: Guideline adherence for heart health randomized trial
-
Bertoni AG, Bonds DE, Chen H et al. Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. Arch Intern Med 2009;169:678-686
-
(2009)
Arch Intern Med
, vol.169
, pp. 678-686
-
-
Bertoni, A.G.1
Bonds, D.E.2
Chen, H.3
-
9
-
-
70249104198
-
Characteristics, management and attainment of lipid target levels in patients enrolled in Disease Management Program versus those in routine care: LUTZ registry
-
Bestehorn K, Jannowitz C, Karmann B et al. Characteristics, management and attainment of lipid target levels in patients enrolled in Disease Management Program versus those in routine care: LUTZ registry. BMC Public Health 2009;9:280
-
(2009)
BMC Public Health
, vol.9
, pp. 280
-
-
Bestehorn, K.1
Jannowitz, C.2
Karmann, B.3
-
10
-
-
33846116628
-
Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany
-
Bohler S, Scharnagl H, Freisinger F et al. Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis 2007;190:397-407
-
(2007)
Atherosclerosis
, vol.190
, pp. 397-407
-
-
Bohler, S.1
Scharnagl, H.2
Freisinger, F.3
-
11
-
-
83255193890
-
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20, 536 high-risk individuals: A randomised controlled trial
-
Bulbulia R, Bowman L, Wallendszus K et al. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20, 536 high-risk individuals: a randomised controlled trial. Lancet 2011;378:2013-2020
-
(2011)
Lancet
, vol.378
, pp. 2013-2020
-
-
Bulbulia, R.1
Bowman, L.2
Wallendszus, K.3
-
12
-
-
0032721879
-
Why don't physicians follow clinical practice guidelines?: A framework for improvement
-
Cabana MD, Rand CS, Powe NR et al. Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement. J Am Med Ass 1999;282:1458-1465
-
(1999)
J Am Med Ass
, vol.282
, pp. 1458-1465
-
-
Cabana, M.D.1
Rand, C.S.2
Powe, N.R.3
-
13
-
-
0347112535
-
-
QuickStats: Age-Adjusted Death Rates for Heart Disease and Cancer - United States, Letzter Zugriff 3.12.2011
-
∗ http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6021a6.htm?s-cid=mm6021a6-w Letzter Zugriff 3.12.2011
-
(1999)
Morbidity and Mortality Weekly Report (MMWR)
-
-
-
14
-
-
79951557873
-
National, regional, and global trends in systolic blood pressure since 1980: Systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants
-
Danaei G, Finucane MM, Lin JK et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011;377:568-577
-
(2011)
Lancet
, vol.377
, pp. 568-577
-
-
Danaei, G.1
Finucane, M.M.2
Lin, J.K.3
-
15
-
-
73449118565
-
Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease
-
Diehm C, Allenberg JR, Pittrow D et al. Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease. Circulation 2009;120:2053-2061
-
(2009)
Circulation
, vol.120
, pp. 2053-2061
-
-
Diehm, C.1
Allenberg, J.R.2
Pittrow, D.3
-
16
-
-
84863085365
-
The ezetimibe controversy - Can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?
-
Doggrell SA. The ezetimibe controversy - can this be resolved by comparing the clinical trials with simvastatin and ezetimibe alone and together?. Expert Opin Pharmacother 2012;13:1469-1480
-
(2012)
Expert Opin Pharmacother
, vol.13
, pp. 1469-1480
-
-
Doggrell, S.A.1
-
17
-
-
85041854741
-
-
European Epidemiology Federation. Good Epidemiological Practice GEP:, Updated, Letzter Zugriff 26.06.2012
-
European Epidemiology Federation. Good Epidemiological Practice (GEP): Proper Conduct in Epidemiologic Research. Updated 2007. http://www.ieaweb.org/index.php?view=article&catid=20%3Agoodepidemiological-practice-gep&id=15%3Agood-epidemiologicalpractice-gep&format=pdf&option=com-content&Itemid=43 Letzter Zugriff 26.06.2012
-
(2007)
Proper Conduct in Epidemiologic Research
-
-
-
18
-
-
0035897696
-
Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)
-
Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults
-
Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
19
-
-
79951550993
-
National, regional, and global trends in serum total cholesterol since 1980: Systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants
-
Farzadfar F, Finucane MM, Danaei G et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011;377:578-586
-
(2011)
Lancet
, vol.377
, pp. 578-586
-
-
Farzadfar, F.1
Finucane, M.M.2
Danaei, G.3
-
20
-
-
79951558318
-
National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants
-
Finucane MM, Stevens GA, Cowan MJ et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377:557-567
-
(2011)
Lancet
, vol.377
, pp. 557-567
-
-
Finucane, M.M.1
Stevens, G.A.2
Cowan, M.J.3
-
22
-
-
37149057185
-
Achievement of guideline-defined treatment goals in primary care: The German Coronary Risk Management (CoRiMa) study
-
Geller JC, Cassens S, Brosz M et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study. Eur Heart J 2007; ehm520
-
(2007)
Eur Heart J
, pp. ehm520
-
-
Geller, J.C.1
Cassens, S.2
Brosz, M.3
-
23
-
-
70349193237
-
Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: The 2L cardio registry
-
Gitt AK, Juenger C, Jannowitz C et al. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry. Eur J Cardiovasc Prev Rehabil 2009;16:438-444
-
(2009)
Eur J Cardiovasc Prev Rehabil
, vol.16
, pp. 438-444
-
-
Gitt, A.K.1
Juenger, C.2
Jannowitz, C.3
-
24
-
-
78649664457
-
Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany
-
Gitt AK, Junger C, Smolka W et al. Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany. Clin Res Cardiol 2010;99:723-733
-
(2010)
Clin Res Cardiol
, vol.99
, pp. 723-733
-
-
Gitt, A.K.1
Junger, C.2
Smolka, W.3
-
25
-
-
33745155419
-
Primary prevention of ischemic stroke. A guideline from the American Heart Association/American stroke association stroke council
-
01.STR00002230480000270103.F0000223041
-
Goldstein LB, Adams R, Alberts MJ et al. Primary Prevention of Ischemic Stroke. A Guideline From the American Heart Association/American Stroke Association Stroke Council. Stroke 2006;01. STR.0000223048.0000270103. F0000223041
-
(2006)
Stroke
-
-
Goldstein, L.B.1
Adams, R.2
Alberts, M.J.3
-
26
-
-
78650023399
-
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults
-
Executive summary a report of the American college of cardiology foundation/American Heart Association task force on practice guidelines developed in collaboration with the American society of echocardiography, American society of nuclear cardiology, society of atherosclerosis imaging and prevention, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, and society for cardiovascular magnetic resonance
-
Greenland P, Alpert JS, Beller GA et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2010;56:2182-2199
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 2182-2199
-
-
Greenland, P.1
Alpert, J.S.2
Beller, G.A.3
-
29
-
-
0037490080
-
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis
-
Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Brit Med J 2003;326:1423-1430
-
(2003)
Brit Med J
, vol.326
, pp. 1423-1430
-
-
Law, M.R.1
Wald, N.J.2
Rudnicka, A.R.3
-
30
-
-
77649126524
-
Heart disease and stroke statistics - 2010 update: A report from the American Heart Association
-
Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010;121:e46-e215
-
(2010)
Circulation
, vol.121
, pp. e46-e215
-
-
Lloyd-Jones, D.1
Adams, R.J.2
Brown, T.M.3
-
31
-
-
76349121984
-
Defining and setting national goals for cardiovascular health promotion and disease reduction
-
Lloyd-Jones DM, Hong Y, Labarthe D et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction. Circulation 2010;121:586-613
-
(2010)
Circulation
, vol.121
, pp. 586-613
-
-
Lloyd-Jones, D.M.1
Hong, Y.2
Labarthe, D.3
-
32
-
-
34547615709
-
2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC)
-
Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536
-
(2007)
Eur Heart J
, vol.28
, pp. 1462-1536
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
-
33
-
-
79956099377
-
Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: Systematic review and meta-analysis
-
Mikhailidis DP, Lawson RW, McCormick AL et al. Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis. Curr Med Res Opin 2011;27:1191-1210
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 1191-1210
-
-
Mikhailidis, D.P.1
Lawson, R.W.2
McCormick, A.L.3
-
34
-
-
34548125027
-
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy
-
Mikhailidis DP, Sibbring GC, Ballantyne CM et al. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin 2007;23:2009-2026
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 2009-2026
-
-
Mikhailidis, D.P.1
Sibbring, G.C.2
Ballantyne, C.M.3
-
35
-
-
18244390229
-
A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: The ezetimibe add-on to statin for effectiveness (EASE) trial
-
Pearson TA, Denke MA, McBride PE et al. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc 2005;80:587-595
-
(2005)
Mayo Clin Proc
, vol.80
, pp. 587-595
-
-
Pearson, T.A.1
Denke, M.A.2
McBride, P.E.3
-
37
-
-
0036315642
-
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: The gap between treatment guidelines and real life treatment patterns
-
Ruof J, Klein G, März W et al. Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns. Prev Med 2002;35:48-53
-
(2002)
Prev Med
, vol.35
, pp. 48-53
-
-
Ruof, J.1
Klein, G.2
März, W.3
-
38
-
-
42149084993
-
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: A population study of 3.3 million people
-
Schramm TK, Gislason GH, Kober L et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008;117:1945-1954
-
(2008)
Circulation
, vol.117
, pp. 1945-1954
-
-
Schramm, T.K.1
Gislason, G.H.2
Kober, L.3
-
39
-
-
33744982042
-
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute
-
Smith SC Jr, Allen J, Blair SN et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-2372
-
(2006)
Circulation
, vol.113
, pp. 2363-2372
-
-
Smith, S.C.1
Allen, J.2
Blair, S.N.3
-
40
-
-
84863893994
-
Safety profile of statins alone or combined with ezetimibe: A pooled analysis of 27 studies including over 22, 000 patients treated for 6-24 weeks
-
Toth PP, Morrone D, Weintraub WS et al. Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22, 000 patients treated for 6-24 weeks. Int J Clin Pract 2012;66:800-812
-
(2012)
Int J Clin Pract
, vol.66
, pp. 800-812
-
-
Toth, P.P.1
Morrone, D.2
Weintraub, W.S.3
-
41
-
-
4444382796
-
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
-
Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952
-
(2004)
Lancet
, vol.364
, pp. 937-952
-
-
Yusuf, S.1
Hawken, S.2
Ounpuu, S.3
|